Flucloxacillin in chronic leg ulcers. Penetration of flucloxacillin into chronic leg ulcer exudate and the effect on the bacteria
- PMID: 3673578
- DOI: 10.1111/j.1699-0463.1987.tb03115.x
Flucloxacillin in chronic leg ulcers. Penetration of flucloxacillin into chronic leg ulcer exudate and the effect on the bacteria
Abstract
The penetration of flucloxacillin into ulcer exudate was investigated in six patients with chronic leg ulcers. The flucloxacillin dosage used was 1 g orally three times daily for three days, and the serum and exudate concentrations were measured repeatedly during a 10 h-period following the first and the seventh dose. All the ulcers were contaminated with (S. aureus) Staphylococcus aureus either in pure culture (three ulcers) or in culture mixed with Gram-negative bacteria (three ulcers). Bacterial counting in the ulcers was performed twice before and twice during the antibiotic treatment. The flucloxacillin concentrations measured in the ulcer exudate were found to be lower than the corresponding serum concentrations. However, the exudate concentrations were found to be above the minimum inhibitory concentration (MIC) for the contaminating S. aureus during an average of 7 h after each dose, and the number of S. aureus during the treatment period was reduced to less than 0.01% of the initial number. The Gram-negative bacteria were not susceptible to flucloxacillin. The number of these bacteria decreased before flucloxacillin treatment but increased again during treatment, probably owing to the changed conditions in the ulcers following the marked decrease in the number of S. aureus.
Similar articles
-
Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmakokinetic evaluation.Scand J Infect Dis. 1980;12(3):221-5. doi: 10.3109/inf.1980.12.issue-3.10. Scand J Infect Dis. 1980. PMID: 7433922
-
Flucloxacillin treatment of methicillin-'resistant' and sensitive staphylococcal infection.J Antimicrob Chemother. 1979 Jul;5(4):359-64. doi: 10.1093/jac/5.4.359. J Antimicrob Chemother. 1979. PMID: 489489 Clinical Trial. No abstract available.
-
Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study.Drug Des Devel Ther. 2017 Jun 14;11:1729-1736. doi: 10.2147/DDDT.S138888. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28652709 Free PMC article.
-
Flucloxacillin does not achieve therapeutic cerebrospinal fluid levels against meticillin-sensitive Staphylococcus aureus in adults: A case report and review of the literature.Int J Antimicrob Agents. 2016 Mar;47(3):229-31. doi: 10.1016/j.ijantimicag.2015.12.009. Epub 2016 Jan 15. Int J Antimicrob Agents. 2016. PMID: 26915477 Review.
-
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.Expert Rev Anti Infect Ther. 2015 May;13(5):605-13. doi: 10.1586/14787210.2015.1023291. Epub 2015 Mar 8. Expert Rev Anti Infect Ther. 2015. PMID: 25746414 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical